RA CAPITAL MANAGEMENT, L.P. Diversified Active

CIK: 0001346824 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $969,369 (100.0% shares, 0.0% debt)

Holdings (30)

WVE WAVE LIFE SCIENCES PTE LTD 23.7%
Value ($000) $230,168 Shares 7,088,651 Est. Cost $15.68 Unrealized +50.7%
ACHILLION PHARMACEUTICALS INC 10.1%
Value ($000) $97,469 Shares 12,033,220 Est. Cost $6.45 Unrealized
ASND ASCENDIS PHARMA A S 7.6%
Value ($000) $73,998 Shares 3,681,491 Est. Cost $16.44 Unrealized
AVEXIS INC 7.4%
Value ($000) $71,387 Shares 1,732,274 Est. Cost $30.41 Unrealized
AXOVANT SCIENCES LTD 7.2%
Value ($000) $70,000 Shares 5,000,000 Est. Cost $20.38 Unrealized
NEKTAR THERAPEUTICS 6.5%
Value ($000) $62,950 Shares 3,664,154 Est. Cost $14.17 Unrealized
ARDX ARDELYX INC 4.4%
Value ($000) $42,263 Shares 3,266,045 Est. Cost $10.51 Unrealized -0.4%
ACRS ACLARIS THERAPEUTICS INC 4.1%
Value ($000) $39,623 Shares 1,547,152 Est. Cost $19.34 Unrealized +9.7%
TGTX TG THERAPEUTICS INC 3.7%
Value ($000) $35,845 Shares 4,631,114 Est. Cost $10.06 Unrealized -36.1%
MERUS N V 3.2%
Value ($000) $31,451 Shares 2,656,166 Est. Cost $13.32 Unrealized
AQUINOX PHARMACEUTICALS INC 3.0%
Value ($000) $29,285 Shares 2,191,977 Est. Cost $13.67 Unrealized
AIMMUNE THERAPEUTICS INC 2.0%
Value ($000) $19,394 Shares 1,292,940 Est. Cost $20.75 Unrealized
FOAMIX PHARMACEUTICALS LTD 1.7%
Value ($000) $16,854 Shares 1,820,138 Est. Cost $9.26 Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 1.6%
Value ($000) $15,941 Shares 754,411 Est. Cost $13.67 Unrealized 0.0%
PROTEON THERAPEUTICS INC 1.6%
Value ($000) $15,179 Shares 1,626,931 Est. Cost $11.31 Unrealized
DICERNA PHARMACEUTICALS INC 1.5%
Value ($000) $14,280 Shares 2,428,571 Est. Cost $28.25 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 1.4%
Value ($000) $13,185 Shares 2,989,795 Est. Cost $9.58 Unrealized -58.3%
STRONGBRIDGE BIOPHARMA PLC 1.3%
Value ($000) $13,059 Shares 2,501,667 Est. Cost $7.60 Unrealized
AUDENTES THERAPEUTICS INC 1.3%
Value ($000) $12,599 Shares 707,426 Est. Cost $17.81 Unrealized
DIMENSION THERAPEUTICS INC 1.3%
Value ($000) $12,369 Shares 1,548,033 Est. Cost $10.25 Unrealized
ACCELERON PHARMA INC 1.2%
Value ($000) $11,529 Shares 318,565 Est. Cost $36.19 Unrealized
ARWR ARROWHEAD PHARMACEUTICALS INC 1.2%
Value ($000) $11,212 Shares 1,525,424 Est. Cost $6.48 Unrealized 0.0%
TENAX THERAPEUTICS INC 0.6%
Value ($000) $5,532 Shares 2,389,700 Est. Cost $3.92 Unrealized
ONC BEIGENE LTD 0.5%
Value ($000) $5,238 Shares 170,000 Est. Cost $29.31 Unrealized
ALCOBRA LTD 0.5%
Value ($000) $5,051 Shares 2,044,756 Est. Cost $6.39 Unrealized
EIGER BIOPHARMACEUTICALS INC 0.5%
Value ($000) $4,743 Shares 354,200 Est. Cost $16.17 Unrealized
SGMO SANGAMO BIOSCIENCES INC 0.4%
Value ($000) $4,164 Shares 899,438 Est. Cost $8.61 Unrealized -40.9%
AEGLEA BIOTHERAPEUTICS INC 0.2%
Value ($000) $2,155 Shares 336,134 Est. Cost $4.86 Unrealized
ARCA BIOPHARMA INC 0.2%
Value ($000) $1,476 Shares 521,606 Est. Cost $4.96 Unrealized
AKARI THERAPEUTICS PLC 0.1%
Value ($000) $970 Shares 114,039 Est. Cost $24.00 Unrealized